Whither Withering’s Legacy?: Digoxin’s Role in Our Contemporary Pharmacopeia for Heart Failure
- 2 August 2005
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 46 (3) , 505-507
- https://doi.org/10.1016/j.jacc.2005.05.014
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Relationship of Serum Digoxin Concentration to Mortality and Morbidity in Women in the Digitalis Investigation Group TrialJournal of the American College of Cardiology, 2005
- The Effect of Gender on Outcome in Digitalis-Treated Heart Failure PatientsJournal of Cardiac Failure, 2005
- Digitalis Therapy for Patients in Clinical Heart FailureCirculation, 2004
- Association of Serum Digoxin Concentration and Outcomes in Patients With Heart FailureJAMA, 2003
- End of the Oldest Controversy in Medicine — Are We Ready to Conclude the Debate on Digitalis?New England Journal of Medicine, 1997
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997
- The use of digitalis in heart failureCurrent Problems in Cardiology, 1996
- Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trialJournal of the American College of Cardiology, 1993
- Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme InhibitorsNew England Journal of Medicine, 1993
- Review of randomized trials of digoxin therapy in patients with chronic heart failureThe American Journal of Cardiology, 1992